ProPhase Labs, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
ProPhase Labs, Inc. (PRPH) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $1.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2025-08-13
- 2025-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.00K.
- 2025-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.67M.
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.79M.
- 2024-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.91M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-06-30 | $1.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $1.67M 10-Q · filed 2025-05-20 |
| 2024-12-31 | $1.79M 10-K · filed 2025-04-01 |
| 2024-09-30 | $1.91M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $2.03M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $2.15M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $2.28M 10-K · filed 2024-03-29 |
| 2023-09-30 | $2.42M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $2.55M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $2.35M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $2.35M 10-K · filed 2023-03-29 |
| 2022-09-30 | $2.47M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $2.58M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $2.70M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $2.83M 10-K · filed 2022-03-31 |
| 2021-09-30 | $2.95M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $3.07M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $3.19M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $3.31M 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |